Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan

Chao Neng Cheng; Sin Syue Li; Yun Hsuan Yeh; Ching Fen Shen; Jiann Shiuh Chen

doi:10.1016/j.jmii.2022.01.002

Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan

Chao Neng Cheng
, Sin Syue Li
, Yun Hsuan Yeh
, Ching Fen Shen
, Jiann Shiuh Chen

Research output: Contribution to journal › Article › peer-review

23 Citations (Scopus)

Abstract

From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.

Original language	English
Pages (from-to)	323-327
Number of pages	5
Journal	Journal of Microbiology, Immunology and Infection
Volume	55
Issue number	2
DOIs	https://doi.org/10.1016/j.jmii.2022.01.002
Publication status	Published - 2022 Apr

All Science Journal Classification (ASJC) codes

Immunology and Allergy
General Immunology and Microbiology
Microbiology (medical)
Infectious Diseases

Access to Document

10.1016/j.jmii.2022.01.002

Cite this

@article{63b6b281fc4d4de7ab6bf793d1ff0e59,

title = "Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan",

abstract = "From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.",

author = "Cheng, \{Chao Neng\} and Li, \{Sin Syue\} and Yeh, \{Yun Hsuan\} and Shen, \{Ching Fen\} and Chen, \{Jiann Shiuh\}",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = apr,

doi = "10.1016/j.jmii.2022.01.002",

language = "English",

volume = "55",

pages = "323--327",

journal = "Journal of Microbiology, Immunology and Infection",

issn = "1684-1182",

publisher = "Elsevier Limited",

number = "2",

}

Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan. / Cheng, Chao Neng ; Li, Sin Syue; Yeh, Yun Hsuan et al.
In: Journal of Microbiology, Immunology and Infection, Vol. 55, No. 2, 04.2022, p. 323-327.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation

T2 - A single-institute experience in Taiwan

AU - Cheng, Chao Neng

AU - Li, Sin Syue

AU - Yeh, Yun Hsuan

AU - Shen, Ching Fen

AU - Chen, Jiann Shiuh

PY - 2022/4

Y1 - 2022/4

N2 - From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.

AB - From January 2019 to May 2021, 11 children underwent allogeneic stem cell transplantation at our institute. Four of them received letermovir for cytomegalovirus prophylaxis. Three children, none of whom received prophylaxis, experienced cytomegalovirus reactivation. Letermovir is a promising medication for use in cytomegalovirus prophylaxis in children. Further studies are warranted.

UR - https://www.scopus.com/pages/publications/85125439476

UR - https://www.scopus.com/pages/publications/85125439476#tab=citedBy

U2 - 10.1016/j.jmii.2022.01.002

DO - 10.1016/j.jmii.2022.01.002

M3 - Article

C2 - 35241378

AN - SCOPUS:85125439476

SN - 1684-1182

VL - 55

SP - 323

EP - 327

JO - Journal of Microbiology, Immunology and Infection

JF - Journal of Microbiology, Immunology and Infection

IS - 2

ER -

Letermovir prophylaxis for cytomegalovirus reactivation in children who underwent hematopoietic stem cell transplantation: A single-institute experience in Taiwan

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this